Navigation Links
Global Small Molecule Kinase Inhibitors Market to Reach $16.2 Billion by 2015, According to a New Report by Global Industry Analysts, Inc.
Date:6/30/2009

GIA announces the release of a comprehensive global report on Small Molecule Kinase Inhibitors market. World market for small molecule kinase inhibitor drugs is projected to reach $16.2 billion by the year 2015. This is primarily driven by the rising interest over the potential of kinase inhibitors in effectively blocking, and modifying protein kinase triggered tumor cell metabolism, proliferation, and DNA damage. Strong growth in the future will be led by expansion of treatment indications in both oncology, and non-oncology disease areas.

San Jose, CA (PRWEB) June 30, 2009 -- With over 500 identified types of kinase proteins in the human body, its little surprise that these enzymes continue to remain important drug targets for major pharmaceutical drug developers, especially in the oncology space. Given their role in effectively disrupting cell signal pathways, kinase inhibitors are of special interest in the treatment of cancer. The unprecedented success witnessed in patient outcomes with the use of currently commercialized kinase inhibitors, such as, imatinib, among others, has ignited excitement over the untapped potential of this very potent class of drugs. Rising incidences of cancer, and the yet unmet treatment needs offer a strong business case for kinase inhibitors.    

The upcoming years are forecast to witness both the strong growth for multi-targeted kinase inhibitors, and the rising popularity of combination drug therapies. Growing incidences of tumor cell resistance to single targeted kinase inhibitor drugs is fingered as the key reason triggering interest in both combination drug therapies, and multi-targeted kinase inhibitors. For instance, growing incidences of resistance to Gleevec, has turned the spotlight on Nexavar, and Sutent, given the potential of these new drugs to offer the much awaited solution to the treatment impasse hitherto encountered. The
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related biology technology :

1. Global Prescription Drugs Market to Cross $897 Billion by 2015, According to New Report by Global Industry Analysts, Inc.
2. Cell Therapeutics Added to Russell 3000(R), Russell 2000(R) and Russell Global(R) Indexes
3. BioStorage Technologies, Inc., Appoints Jeff Goddard to Global Head of Sales
4. Mylan Announces Strategic Collaboration with Biocon to Enter the Global Generic Biologics Market
5. deCODE Reinstated to Nasdaq Global Market
6. BIO Ventures for Global Health Announces Management Changes
7. World Nanomedicine Market to Cross $160 Billion by 2015, According to New Report by Global Industry Analysts, Inc.
8. Galichia Heart Hospital Partners with Mobile Surgery International to Develop Wichita-based Center of Excellence with Global Convenience(TM)
9. Sugarcane as a Key Element Against Global Warming to be Highlighted at Green Week in Brussels
10. BD and FIND Achieve Milestone in Global Battle Against MDR-TB
11. Springborn Deploys eStudy(TM) Hosted Solution for Management of Global Environmental Testing
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Global Small Molecule Kinase Inhibitors Market to Reach $16.2 Billion by 2015, According to a New Report by Global Industry Analysts, Inc.
(Date:9/16/2014)... “Nature has developed, very cleverly, some ... desire in optical design,” said Joseph Shaw, director of ... we explore surfaces and structures at the nanoscale, we’ll ... in San Diego in August during a conference called ... chaired by Shaw and Rongguang Liang of the University ...
(Date:9/16/2014)... From cell phones to cars and flashlights, batteries ... and technology companies constantly are seeking ways to ... first time using a water-based solution, researchers at ... and more efficient nuclear battery that could be ... energy source in automobiles and also in complicated ...
(Date:9/16/2014)... CIRTEC Medical Systems’ Board of Directors has ... CIRTEC. , “I am delighted to be joining ... Brian Highley. “The company has made great strides improving ... over the past two years. The goal now is ... expand the services Cirtec offers its medical device customers.” ...
(Date:9/16/2014)... , Sept. 16, 2014  LABSCO, the ... and products to hospitals, physician office laboratories and ... effective October 1, 2014, it will serve as ... hospital market segments and as a semi-exclusive sales ... 48 contiguous United States . ...
Breaking Biology Technology:Nature’s designs inspire research into new light-based technologies 2Nature’s designs inspire research into new light-based technologies 3Nature’s designs inspire research into new light-based technologies 4Nature’s designs inspire research into new light-based technologies 5LABSCO Secures Alliance With Siemens Healthcare Diagnostics 2LABSCO Secures Alliance With Siemens Healthcare Diagnostics 3
... Merrimack Pharmaceuticals, Inc. announced today that it ... therapeutic consisting of a mixture of three human ... irinotecan, at the 14th World Conference on Lung ... in Amsterdam, The Netherlands. (Logo: ...
... Dendreon Corporation (Nasdaq: DNDN ) today ... approved its Los Angeles cancer immunotherapy manufacturing facility, allowing ... PROVENGE ® (sipuleucel-T) across the U.S. to help ... symptomatic metastatic castrate resistant (hormone refractory) prostate cancer.   ...
... Branch Fund: A Thisbe and Noah Scott Legacy, an ... announced its first funding award to Kevin Eggan, Ph.D., ... Harvard University.  The award will support Dr. Eggan,s ongoing ... affect it.  Dr. Eggan is a leading researcher in ...
Cached Biology Technology:Merrimack Announces Presentation of Preclinical Data at the 14th World Conference on Lung Cancer 2FDA Approves Dendreon's Los Angeles Cancer Immunotherapy Manufacturing Facility 2FDA Approves Dendreon's Los Angeles Cancer Immunotherapy Manufacturing Facility 3FDA Approves Dendreon's Los Angeles Cancer Immunotherapy Manufacturing Facility 4The Olive Branch Fund Announces Funding Award to Harvard Researcher 2
(Date:9/16/2014)... us that we inherit certain traits from our parents ... how these genes play out by taking certain drugs ... exactly what a team of researchers at the Boston ... research of epigenetics research. , Epigenetics regulates gene ... and histone proteins, which prevent permanent mutations or alterations ...
(Date:9/16/2014)... Each tree species has its own bacterial identity. That,s ... from other institutions who studied the genetic fingerprints of ... Panamanian island. , "This study demonstrates for the first ... with different ecological strategies possess very different microbial communities ... a former postdoctoral researcher in the UO,s Institute of ...
(Date:9/16/2014)... diameter chunk of rock hit the Yukatan peninsula near the ... of 100 teratons of TNT. It left a crater more ... earthquakes and volcanism are widely accepted to have wiped out ... mammals. But what happened to the plants on which the ... the University of Arizona reveals that the meteorite impact that ...
Breaking Biology News(10 mins):Epigenetic drugs: A hope to treat cancer resistance and reduce cancer relapse? 2Epigenetic drugs: A hope to treat cancer resistance and reduce cancer relapse? 3Microbiome research shows each tree species has a unique bacterial identity 2Meteorite that doomed the dinosaurs helped the forests bloom 2Meteorite that doomed the dinosaurs helped the forests bloom 3
... The world,s leading conservation organizations have joined together to fight ... gorilla ( Gorilla beringei graueri ). Found only in ... of Congo (DRC), Grauer,s gorilla is not only the largest ... in the world. With their entire range consumed in ...
... and walked on two legs is considered to be one of ... to the far ends of the earth and the wonderful ... walk the way we walk. In the latest such search, ... have taken a closer look at bipedal kangaroos and wallabies and ...
... PA, March 13, 2013 Many Canadians are concerned ... sodium intake through a variety of measures, including lowering ... a national survey. The top barriers to limiting sodium ... processed foods and lower sodium restaurant menu options. ...
Cached Biology News:Gorillas caught in the crossfire in the DRC 2Gorillas caught in the crossfire in the DRC 3It's all in the way we move 2Canadians support interventions to reduce dietary salt 2
Cag-A (IgG) -Ab EIA Sample Size: 10 l...
... inhibitor that noncovalently binds and inactivates neutral pancreatic ... RNase 1, T1, T2, H, U1, U2 or ... inhibitor in that it has a more robust ... RNase in the absence of DTT or other ...
... Inhibitor is a recombinant protein that has been ... in the preparation of cDNA by reverse transcription, ... protein synthesis. RNA Safe Inhibitor tightly binds RNases ... range of eukaryotic RNases such as RNase A, ...
... and Recombinant RNasin Ribonuclease Inhibitors have broad ... of eukaryotic RNases of the neutral type ... effect by noncovalently binding to RNases in ... the binding of RNasin Ribonuclease Inhibitor to ...
Biology Products: